BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:53 PM
 | 
Jul 02, 2007
 |  BC Extra  |  Top Story

Novartis, Intercell vaccines deal

Intercell (VSE:ICLL) and Novartis (NVS; SWX:NOVN) announced a vaccines partnership in which NVS will receive exclusive, worldwide rights to ICLL's IC31 adjuvant for influenza vaccines as well as opt in rights to ICLL's non-partnered vaccines. ICLL will receive EUR 120 million ($162.4 million) up front and a EUR 150 million ($203 million) equity investment from NVS. The pharma company is buying 4.8...

Read the full 300 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >